TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9689372

Group type: EXPERIMENTAL
Intervention: Bupivacaine with epinephrine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Bupivacaine and morphine with epinephrine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo with epinephrine
Number of subjects: 30
Study: 7639651

Group type: EXPERIMENTAL
Intervention: 2.0% dorzolamide three times a day
Number of subjects: 523

Group type: COMPARATOR
Intervention: 0.5% timolol twice daily
Number of subjects: 523

Group type: COMPARATOR
Intervention: 0.5% betaxolol twice daily
Number of subjects: 523
Study: 2541335

Group type: EXPERIMENTAL
Intervention: Acyclovir (800 to 3200 mg per day, starting 6 hours before transplantation for 12 weeks)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Acyclovir
Number of subjects: 118

Group type: COMPARATOR
Intervention: Acyclovir and Placebo
Number of subjects: 118
Study: 12113

Group type: EXPERIMENTAL
Intervention: Bromazepam (0.1 mg/kg b.w. i.v.)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study: 31806692

Group type: EXPERIMENTAL
Intervention: Local Anesthesia (LA)
Number of subjects: 1376

Group type: COMPARATOR
Intervention: General Anesthesia (GA)
Number of subjects: 1376

Group type: COMPARATOR
Intervention: Conscious Sedation (CS)
Number of subjects: 1376
Study: 30362878

Group type: EXPERIMENTAL
Intervention: High-intensity locomotor training (LT) (70-85% HRmax)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-intensity locomotor training (LT) (50-65% HRmax)
Number of subjects: 0
Study: 28433774

Group type: EXPERIMENTAL
Intervention: Unhealthy snack condition
Number of subjects: 232

Group type: COMPARATOR
Intervention: Fruit and vegetable condition
Number of subjects: 232
Study: 24908097

Group type: EXPERIMENTAL
Intervention: Propranolol (n = 33)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (n = 33)
Number of subjects: 66
Study: 23171498

Group type: EXPERIMENTAL
Intervention: Manic episodes
Number of subjects: 34653

Group type: EXPERIMENTAL
Intervention: Bipolar disorder (I or II)
Number of subjects: 34653

Group type: EXPERIMENTAL
Intervention: Thought disorder factor
Number of subjects: 34653

Group type: EXPERIMENTAL
Intervention: Disorders characterized by detachment and psychoticism
Number of subjects: 34653

Group type: EXPERIMENTAL
Intervention: Manic episodes and bipolar disorder
Number of subjects: 34653
Study: 20825887

Group type: EXPERIMENTAL
Intervention: Airway Scope (AWS) with chest compressions
Number of subjects: 22

Group type: COMPARATOR
Intervention: Macintosh with chest compressions
Number of subjects: 22

Group type: COMPARATOR
Intervention: GlideScope (GVL) with chest compressions
Number of subjects: 22

Group type: COMPARATOR
Intervention: Airway Scope (AWS) without chest compressions
Number of subjects: 22
Study: 19845979

Group type: EXPERIMENTAL
Intervention: Minimal psychological intervention (MPI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 16882344

Group type: EXPERIMENTAL
Intervention: Carboplatin AUC 5 plus pegylated liposomal doxorubicin 30 mg/m2, every 3 weeks
Number of subjects: 50
Study: 14990150

Group type: EXPERIMENTAL
Intervention: Hyperoxygen compound sodium chloride solution (HCSCS)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control sodium chloride solution (CSCS)
Number of subjects: 2
Study: 15001936

Group type: EXPERIMENTAL
Intervention: Hepatitis A vaccine (group 1)
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Hepatitis A vaccine (group 2)
Number of subjects: 285

Group type: COMPARATOR
Intervention: Hepatitis B vaccine (group 3)
Number of subjects: 285
Study: 10700492

Group type: EXPERIMENTAL
Intervention: Abciximab (54 patients)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo (20 patients)
Number of subjects: 74
Study: 9113846

Group type: EXPERIMENTAL
Intervention: $5.00 suggested donation for helmets
Number of subjects: 506

Group type: COMPARATOR
Intervention: Free helmet distribution
Number of subjects: 506
Study: 8226141

Group type: EXPERIMENTAL
Intervention: Fast neutron radiation therapy (20.4 Gy in 12 fractions)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional photon radiotherapy (66 Gy in 33 fractions)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Fast neutron radiation therapy
Number of subjects: 200
Study: 3768575

Group type: EXPERIMENTAL
Intervention: Placebo (inhaled aerosol described as a powerful new drug)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Bronchoconstrictive suggestion (inhaled nebulized water described as likely to cause chest tightness and wheezing)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (distilled nebulized water inhaled without suggestion)
Number of subjects: 12
Study: 2738335

Group type: EXPERIMENTAL
Intervention: Tourniquet application during carpal tunnel release
Number of subjects: 60

Group type: COMPARATOR
Intervention: No tourniquet application during carpal tunnel release
Number of subjects: 60
Study: 30838646

Group type: EXPERIMENTAL
Intervention: Concentration-based HIPEC
Number of subjects: 31

Group type: COMPARATOR
Intervention: BSA-based HIPEC
Number of subjects: 31
Study: 28350929

Group type: EXPERIMENTAL
Intervention: Vitamin D3 + Calcium (2000 IU/d of vitamin D3 and 1500 mg/d of calcium)
Number of subjects: 2303

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2303

Group type: EXPERIMENTAL
Intervention: Vitamin D3 + Calcium
Number of subjects: 2303
Study: 25470475

Group type: EXPERIMENTAL
Intervention: ReliefBand (P6 acustimulation)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Sham ReliefBand
Number of subjects: 62
Study: 23303057

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (HCT) 25 mg/day over 4 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (HCT) 100 mg single dose
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22013791

Group type: EXPERIMENTAL
Intervention: Electro-acupuncture combined with sevoflurane anesthesia (Group B)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sevoflurane anesthesia (Group A)
Number of subjects: 80
Study: 19242864

Group type: EXPERIMENTAL
Intervention: Leaflet on ecstasy use
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GHB materials (leaflet and infocard)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Infocard about GHB
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Leaflet about GHB
Number of subjects: 0

Group type: COMPARATOR
Intervention: Leaflet vs. infocard about ecstasy
Number of subjects: 0
Study: 17541316

Group type: EXPERIMENTAL
Intervention: 12-week home‐based walking intervention (n=13)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Education-only program (control, n=10)
Number of subjects: 23
Study: 15138958

Group type: EXPERIMENTAL
Intervention: Cooking stove used inside a tent for 120 minutes
Number of subjects: 7
Study: 11806595

Group type: EXPERIMENTAL
Intervention: Slow music
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Fast music
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Music personally selected by subjects
Number of subjects: 48

Group type: COMPARATOR
Intervention: No music (control)
Number of subjects: 48
Study: 9493587

Group type: EXPERIMENTAL
Intervention: 90 anti-Xa IU x kg(-1) b.i.d. of the 10,250 IU preparation (treatment A)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 180 anti-Xa IU x kg(-1) o.d. of the 20,500 IU preparation (treatment B)
Number of subjects: 12
Study: 8301432

Group type: EXPERIMENTAL
Intervention: Manual chest percussion
Number of subjects: 51

Group type: COMPARATOR
Intervention: Mechanical chest percussion
Number of subjects: 51
Study: 2500040

Group type: EXPERIMENTAL
Intervention: IV nitroglycerin 1 microgram.kg‐1.min‐1 (NTG group)
Number of subjects: 20

Group type: COMPARATOR
Intervention: IV saline (control group)
Number of subjects: 20
Study: 4583184

Group type: EXPERIMENTAL
Intervention: Ketoprofen 150 mg daily
Number of subjects: 35

Group type: COMPARATOR
Intervention: Ibuprofen 1,200 mg daily
Number of subjects: 35
Study: 31957508

Group type: EXPERIMENTAL
Intervention: Canakinumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30775783

Group type: EXPERIMENTAL
Intervention: Panelist‐Articulated‐2‐Alternative Forced Choice (PA‐2‐AFC)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Triangle testing methodologies
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Triangle with partial presentation
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Duo-trio
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Duo-trio with partial presentation
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: 4-category rating methods for R-index measure
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Same-different pairwise comparison for R-index measure
Number of subjects: 61
Study: 28523355

Group type: EXPERIMENTAL
Intervention: Dutasteride 0.5 mg
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 25299832

Group type: COMPARATOR
Intervention: Normal hearing
Number of subjects: 764

Group type: EXPERIMENTAL
Intervention: Bilateral hearing loss
Number of subjects: 764

Group type: EXPERIMENTAL
Intervention: Unilateral hearing loss
Number of subjects: 764
Study: 23785044

Group type: EXPERIMENTAL
Intervention: Cognitive remediation
Number of subjects: 70

Group type: COMPARATOR
Intervention: Physical exercise
Number of subjects: 70
Study: 21784296

Group type: EXPERIMENTAL
Intervention: Behavioral therapy (BT) protocol consisting of eight weekly sessions
Number of subjects: 24

Group type: COMPARATOR
Intervention: Minimal attention control (MAC) condition consisting of three sessions and five telephone calls over 8 weeks
Number of subjects: 24
Study: 19627350

Group type: EXPERIMENTAL
Intervention: Oral health-promotion approach
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Risk-strategy and promotion approach
Number of subjects: 250

Group type: COMPARATOR
Intervention: Reference group (Rauma)
Number of subjects: 250
Study: 16883311

Group type: EXPERIMENTAL
Intervention: G‐CSF and GM‐CSF (5 x 2 microg/kg/day)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: G‐CSF and GM‐CSF (2.5 x 2 microg/kg/day)
Number of subjects: 120

Group type: COMPARATOR
Intervention: G‐CSF (5 microg/kg/day)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: G‐CSF plus GM‐CSF
Number of subjects: 120
Study: 15637216

Group type: EXPERIMENTAL
Intervention: Standard care plus up to 1,375 Kcal [5,755 kJ/d] of nasoenteral tube feedings each night
Number of subjects: 57

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 57
Study: 11556510

Group type: EXPERIMENTAL
Intervention: Intrapulpal anaesthesia with lidocaine hydrochloride 2% (Group A)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Intrapulpal anaesthesia with lidocaine hydrochloride 2% with adrenaline 1:100,000 (Group B)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Anaesthesia with a mandibular block using prilocaine hydrochloride 3% with felypressin 1:100,000 (Group C)
Number of subjects: 41
Study: 9586615

Group type: EXPERIMENTAL
Intervention: Levofloxacin (250 mg once daily for 7 to 10 days)
Number of subjects: 336

Group type: COMPARATOR
Intervention: Lomefloxacin (400 mg once daily for 14 days)
Number of subjects: 336
Study: 8139604

Group type: EXPERIMENTAL
Intervention: Pergolide mesylate
Number of subjects: 376

Group type: COMPARATOR
Intervention: Sinemet (levodopa)
Number of subjects: 376
Study: 2463565

Group type: EXPERIMENTAL
Intervention: DVI/DDD pacing
Number of subjects: 23

Group type: COMPARATOR
Intervention: VVI pacing
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: DVI/DDD pacing (Group A)
Number of subjects: 23

Group type: COMPARATOR
Intervention: VVI pacing (Group B)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Carotid sinus massage during VVI mode
Number of subjects: 23

Group type: COMPARATOR
Intervention: Carotid sinus massage during DVI mode
Number of subjects: 23
Study: 31358482

Group type: EXPERIMENTAL
Intervention: Visit prior to hospital ICU admission
Number of subjects: 38

Group type: COMPARATOR
Intervention: No visit prior to hospital ICU admission (Control)
Number of subjects: 38
Study: 27979046

Group type: EXPERIMENTAL
Intervention: Stress Management (SM) training
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Aerobic Exercise (EX)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 134
Study: 26028058

Group type: EXPERIMENTAL
Intervention: High-protein (HP) breakfast (350 kcal, 35 g protein)
Number of subjects: 28
Study: 24219183

Group type: EXPERIMENTAL
Intervention: Lifetime anhedonia
Number of subjects: 1469

Group type: EXPERIMENTAL
Intervention: Lifetime depressed mood
Number of subjects: 1469

Group type: EXPERIMENTAL
Intervention: Lifetime anhedonia (after controlling for depressed mood)
Number of subjects: 1469

Group type: EXPERIMENTAL
Intervention: Lifetime depressed mood (after controlling for anhedonia)
Number of subjects: 1469
Study: 20625950

Group type: EXPERIMENTAL
Intervention: Cementless THA
Number of subjects: 250

Group type: COMPARATOR
Intervention: Cemented THA
Number of subjects: 250
Study: 19283884

Group type: EXPERIMENTAL
Intervention: All-trans retinoyl glucuronide (RAG) administered orally to Group II (n 42), blood collected 4 hours after dosing.
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (Group I, n 19) not dosed with RAG.
Number of subjects: 61
Study: 17719942

Group type: EXPERIMENTAL
Intervention: Prebiotic supplement
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control (maltodextrin)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Prebiotic supplement (with calcium intake > or = 700 mg/d)
Number of subjects: 97
Study: 15030839

Group type: EXPERIMENTAL
Intervention: Topical anesthesia (lidocaine hydrochloride 2% gel)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Regional anesthesia (peribulbar or retrobulbar injection of lignocaine 2%)
Number of subjects: 76
Study: 11578789

Group type: EXPERIMENTAL
Intervention: Progressive addition lenses (PALs) - Varilux Comfort with a +2.00 D addition
Number of subjects: 469

Group type: COMPARATOR
Intervention: Conventional single vision lenses (SVLs)
Number of subjects: 469
Study: 9390011

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) 0.03 mg/kg
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH)
Number of subjects: 11
Study: 7886391

Group type: EXPERIMENTAL
Intervention: Loperamide (16 mg, orally)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (oral)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Distilled water (intraluminal infusion)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Loperamide (intraluminal infusion)
Number of subjects: 9
Study: 3279743

Group type: EXPERIMENTAL
Intervention: Isosorbide-5-mononitrate (IS-5-MN) 20 mg 3 times a day or 50 mg in a sustained-release tablet
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nifedipine 20 mg in a sustained-release tablet 3 times a day
Number of subjects: 20
Study: 29233569

Group type: EXPERIMENTAL
Intervention: Spinal + CACB
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: General + CACB
Number of subjects: 145

Group type: COMPARATOR
Intervention: CSE
Number of subjects: 145
Study: 27477951

Group type: EXPERIMENTAL
Intervention: Hb‐PTFE grafts
Number of subjects: 569

Group type: COMPARATOR
Intervention: Standard PTFE grafts
Number of subjects: 569
Study: 24996519

Group type: EXPERIMENTAL
Intervention: Lessons with a mirror (mirror-group)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Lessons without a mirror (non-mirror group)
Number of subjects: 64
Study: 22649287

Group type: EXPERIMENTAL
Intervention: Project PATHS program
Number of subjects: 2850

Group type: COMPARATOR
Intervention: Control group (no Project PATHS participation)
Number of subjects: 2850
Study: 20220206

Group type: EXPERIMENTAL
Intervention: Choline intake 300 mg/d
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Choline intake 550 mg/d
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Choline intake 1100 mg/d
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Choline intake 2200 mg/d
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Choline intake 300 mg/d and 550 mg/d
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Choline intake (varied levels)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Choline intake (all levels)
Number of subjects: 60
Study: 18503895

Group type: COMPARATOR
Intervention: Percutaneous transluminal angioplasty (PTA) alone
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: PTA followed by stent-graft placement (expanded polytetrafluoroethylene/nitinol self-expanding stent-graft)
Number of subjects: 197
Study: 15670103

Group type: EXPERIMENTAL
Intervention: Smoking during pregnancy
Number of subjects: 274
Study: 14723030

Group type: EXPERIMENTAL
Intervention: Decompressive surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 0
Study: 10553933

Group type: EXPERIMENTAL
Intervention: Yeast-derived vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Plasma-derived vaccine
Number of subjects: 0
Study: 8572340

Group type: EXPERIMENTAL
Intervention: Propofol/Alfentanil combination
Number of subjects: 10

Group type: COMPARATOR
Intervention: Alfentanil alone
Number of subjects: 10

Group type: COMPARATOR
Intervention: Propofol alone
Number of subjects: 10
Study: 1441044

Group type: EXPERIMENTAL
Intervention: Norfloxacin (400 mg orally twice daily for 10-21 days)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Ciprofloxacin (500 mg orally every 12 hours for 14-21 days)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Norfloxacin
Number of subjects: 72

Group type: COMPARATOR
Intervention: Norfloxacin and Ciprofloxacin
Number of subjects: 72
Study: 3931142

Group type: EXPERIMENTAL
Intervention: Tryptophan-free amino acid mixture
Number of subjects: 3

Group type: COMPARATOR
Intervention: Balanced amino acid mixture
Number of subjects: 3

Group type: COMPARATOR
Intervention: Excess tryptophan amino acid mixture
Number of subjects: 3
Study: 31690824

Group type: EXPERIMENTAL
Intervention: Tyrosine
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 30011900

Group type: EXPERIMENTAL
Intervention: Neurofeedback system training (two protocols with different temporal lengths)
Number of subjects: 6
Study: 24568894

Group type: EXPERIMENTAL
Intervention: Dutasteride (0.5mg/d)
Number of subjects: 6374

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6374
Study: 22782060

Group type: EXPERIMENTAL
Intervention: 4% titanium tetrafluoride (TiF4) applied once with sodium monofluorophosphate (MFP) dentifrice for four weeks
Number of subjects: 8

Group type: COMPARATOR
Intervention: sodium monofluorophosphate (MFP) dentifrice only
Number of subjects: 8
Study: 21143904

Group type: EXPERIMENTAL
Intervention: Low dose rate (LDR) Ra‐226 brachytherapy (n = 4; median 70Gy)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Ir‐192 brachytherapy (n = 12; 70Gy)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Au‐198 brachytherapy (n = 1)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: High dose rate (HDR) Ir‐192 brachytherapy (n = 4; 60 Gy)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: External radiotherapy (8 patients, median 30 Gy)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Cause-specific survival
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Regional control
Number of subjects: 21
Study: 17285183

Group type: EXPERIMENTAL
Intervention: Botulinum toxin (BTX)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 16250032

Group type: EXPERIMENTAL
Intervention: Interferon alfa-2b plus ribavirin 15 mg/kg/d
Number of subjects: 118
Study: 12015628

Group type: EXPERIMENTAL
Intervention: Adult air divers
Number of subjects: 173

Group type: COMPARATOR
Intervention: Young recreational divers
Number of subjects: 173
Study: 10188752

Group type: EXPERIMENTAL
Intervention: 50% of one repetition maximum (1RM)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 80% of one repetition maximum (1RM)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 50% and 80% of one repetition maximum (1RM)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 84
Study: 7473483

Group type: EXPERIMENTAL
Intervention: Grip Ability Test (GAT)
Number of subjects: 24
Study: 2531153

Group type: EXPERIMENTAL
Intervention: Nafarelin (400 micrograms daily)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Danazol (600 mg daily)
Number of subjects: 18
Study: 4921092

Group type: EXPERIMENTAL
Intervention: Use of a computer for clerical work in the trial
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 30488303

Group type: EXPERIMENTAL
Intervention: Image-guided high-dose-rate (HDR) brachytherapy (iBT)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Conventional transarterial chemoembolization (cTACE)
Number of subjects: 77
Study: 28626050

Group type: EXPERIMENTAL
Intervention: Global GM volume
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Lower GM volumes in left fronto‐temporo‐insular cortex
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Lower GM volumes in right temporo‐insular cortex and basal ganglia
Number of subjects: 248
Study: 24997614

Group type: EXPERIMENTAL
Intervention: Combined Training (CT, n=9)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Aerobic Training (AT, n=10)
Number of subjects: 19
Study: 23407006

Group type: EXPERIMENTAL
Intervention: Implementation strategy including patient-facing kiosks, continuous data feedback, clinical champions, education, social marketing, and evidence-based quality improvement teams.
Number of subjects: 571

Group type: EXPERIMENTAL
Intervention: Implementation strategy
Number of subjects: 571

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 571
Study: 21415812

Group type: EXPERIMENTAL
Intervention: Lumbar disc arthroplasty (investigational group)
Number of subjects: 577

Group type: COMPARATOR
Intervention: Anterior lumbar interbody fusion (control group)
Number of subjects: 577
Study: 19356442

Group type: EXPERIMENTAL
Intervention: Regadenoson
Number of subjects: 2015

Group type: COMPARATOR
Intervention: Adenosine
Number of subjects: 2015
Study: 16505085

Group type: EXPERIMENTAL
Intervention: Low intensity active exercise (ACT)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Contrast water therapy (CWT)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Compression garment (GAR)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Passive recovery (PAS)
Number of subjects: 23